References
S. Adami, C. Marcocci, D. Gatti, Epidemiology of primary hyperparathyroidism in Europe. J. Bone Miner. Res. 17(2), 18–23 (2002)
P. Björklund, D.G. Akerström, G. Westin, Accumulation of nonphosphorylated β-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors. J. Clin. Endocrinol. Metab. 92, 338–344 (2007)
P. Björklund, D. Lindberg, G. Akerström, G. Westin, Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients. Mol. Cancer 7, 53 (2008)
S. Semba, R. Kusumi, T. Moriya, H. Sasano, Nuclear accumulation of β-catenin in human endocrine tumors: association with Ki-67 (MIB-1) proliferative activity. Endocrinol. Pathol. 11, 243–250 (2000)
S. Ikeda, Y. Ishizaki, Y. Shimizu, M. Fujimori, Y. Ojima, M. Okajima, K. Sugino, T. Asahara, Immunohistochemistry of cyclin D1 and β-catenin, and mutational analysis of exon 3 of beta-catenin gene in parathyroid adenomas. Int. J. Oncol. 20, 463–466 (2002)
J. Costa-Guda, A. Arnold, 2007 Absence of stabilizing mutations of β-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas. J. Clin. Endocrinol. Metab. 92, 1564–1566 (2007)
F. Cetani, E. Pardi, C. Banti, P. Collecchi, P. Viacava, S. Borsari, G. Fanelli, A.G. Naccarato, F. Saponaro, P. Berti, P. Miccoli, A. Pinchera, C. Marcocci, β-Catenin activation is not involved in sporadic parathyroid carcinomas and adenomas. Endocr. Relat. Cancer 17, 1–6 (2010)
C.C. Juhlin, F. Haglund, A. Villablanca, L. Forsberg, K. Sandelin, R. Branstrom, C. Larsson, A. Höog, Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-β in parathyroid carcinomas. Int. J. Oncol. 34, 481–492 (2009)
F. Haglund, A. Andreasson, I.L. Nilsson, A. Hoög, C. Larsson, C.C. Juhlin, Lack of S37A CTNNB1/β-catenin mutations in a Swedish cohort of 98 parathyroid adenomas. Clin. Endocrinol. (Oxf) 73, 552–553 (2010)
L. Grimelius, R.A. DeLellis, L. Bondeson, G. Akerstrom, A. Arnold, K.O. Frinssila, G.N. Hendy, D. Dupuy, C. Eng, Parathyroid adenoma, in Pathology and genetics of tumours of endocrine organs. WHO classification of tumours, ed. by R.A. DeLellis, R.V. Lloyd, P.U. Heitz, C. Eng (IARC Press, Lyon, 2004), pp. 128–132
W.F. Simonds, Editorial: Ruling out a suspect: the role of β-catenin mutation in benign parathyroid neoplasia. J. Clin. Endocrinol. Metab. 92, 1235–1236 (2007)
Acknowledgments
Supported by Italian Ministry of Health, Ricerca Corrente 2010, ‘Progetto Oncologico 2006’-RF06ED01 and Istituto Superiore di Sanità ‘ITALIA-USA Program 2007-Malattie Rare’ Grant No. 8900000. We gratefully acknowledge the patients and the Families participating this study.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guarnieri, V., Baorda, F., Battista, C. et al. A rare S33C mutation of CTNNB1 encoding β-catenin in a parathyroid adenoma found in an Italian primary hyperparathyroid cohort. Endocrine 41, 152–155 (2012). https://doi.org/10.1007/s12020-011-9558-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-011-9558-y